Market Forecast By Regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa), By Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches), By Hormone (Progestin-Only Contraceptive, Combined Hormonal Contraceptive), By Age Group (15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years), By End-Users (Hospitals, Household, Clinics) And Competitive Landscape
| Product Code: ETC150182 | Publication Date: Dec 2021 | Updated Date: Mar 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
| Report Name | Global Hormonal Contraceptives Market |
| Forecast Period | 2025-2031 |
| Market Size | USD 30.5 billion by 2031 |
| CAGR | 5.8% |
| Growing Sector | Healthcare |
The Global Hormonal Contraceptives Market report provides a detailed analysis of market segments, by regions, product, hormone, age group and end-users. It offers an unbiased examination of current market trends, high-growth areas, and drivers to assist stakeholders in aligning their strategies with evolving market dynamics.
In 2025, the world organic birth control market earned about USD 19.4 billion. This large value of the market is proof for the utilization and dependence on hormone birth control approaches on a global scale. The market is expected to grow and reach about USD 26.8 billion in 2031. This development pattern shows the growing demand for contraception products, especially for women's health worldwide and the persistent efforts to improve their health risks.
The global market share for hormonal contraceptives is made up of different product ranges like contraception pills, IUDs, injectables, vaginal rings, implants, and transdermal patches. These ways make use of progestin-only and combined hormonal combinations to halt the pregnancy process. The increase in the market size depends on the points such as better education of family planning, comprehension of government policies, and technological progress in contraception systems
According to 6Wresearch, the Global Hormonal Contraceptives Market is anticipated to grow at a CAGR of 5.8% during the forecast period 2025-2031. The growth of the global hormonal contraceptives market is driven by several key factors. One of the primary drivers is the growing awareness and education about reproductive health and contraceptive options, which empowers individuals to make informed decisions about family planning. Furthermore, the increasing accessibility to contraceptives, particularly in developing regions, is significantly contributing to market expansion. Supportive government policies, campaigns promoting sexual health, and funding from international organizations have also played a pivotal role in enhancing access to hormonal contraceptives. Additionally, the rising preference for convenient and long-term contraceptive methods, such as implants and intrauterine devices, is fueling demand. Advances in healthcare infrastructure and the development of innovative formulations designed to reduce side effects and improve user experience are also critical drivers shaping the Global Hormonal Contraceptives Market growth.
The newest development that is catching attention in hormonal contraceptives is the preference for long-acting reversible contraceptives (LARCs) such as IUDs and implants. These methods have a prolonged duration of action against pregnancy and need little attention from the user, which has made them very popular for those who are looking for convenient and reliable contraceptive options. The expected growth in the LARCs preference will bring the lift to the market in the coming years.
Say NO to the 3rd way trend is the production and approval AO of OTC contraception that is to be more accessible and convenient for users. Thus, the FDA milestone of having the sale of Opill, a progestin-only birth control pill, approved in the US over the counter, among a host of other developments, can be an instructive case study for making contraception more readily available.
Investors can reap good returns by coming up with new and distinct products that can fulfill the untapped needs in the hormonal contraceptives market. By concentrating on non-hormonal contraceptive methods or those with fewer side effects, the product can become more popular and gain a wider audience, which would include people who were reluctant to use the traditional hormonal options.
Another promising investment dimension is to extend the distribution channels to developing countries. During these regions' ever-increasing exposure and approval of contraceptive techniques, the very first problem to address will be the availability and affordability of these hormonal contraceptives which will help in capturing a significant market share. To bolster market penetration and growth, critiquing with local authorities and organizations to promote family planning programs is a plus.
The market for hormonal contraceptives is considered to consist several key players among them AbbVie Inc., Afaxys, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Organon Group of Companies, Pfizer, Agile Therapeutics, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., and Pregna International Ltd. These companies are not just passively involved in research and development but they are actually the ones who are significantly contributing to the growth of the healthcare sector through strategic partnerships and innovative products that also match the continuously changing consumers’ habits and preferences lines. ”- the company announced.
Government regulations play an essential role in shaping the global hormonal contraceptives market. Regulatory authorities, such as the FDA in the United States and the EMA in the European Union, establish stringent guidelines to ensure the safety, efficacy, and quality of contraceptive products. These regulations govern the approval process for new formulations, manufacturing standards, and post-market surveillance to monitor any adverse effects. Additionally, governments in various regions enforce policies to improve access to contraceptives, including subsidies, distribution through public health programs, and education initiatives. However, regulatory frameworks can vary significantly across countries, creating both opportunities and challenges for market players. Harmonizing these regulations globally could enhance accessibility and innovation in the hormonal contraceptives space, addressing unmet needs and expanding options for users worldwide.
The global hormonal contraceptives market is anticipated to witness significant growth in the coming years, driven by advancements in drug delivery methods and increasing awareness about reproductive health. Trends such as the development of long-acting reversible contraceptives (LARCs), including implants and intrauterine systems, are expected to gain traction due to their efficacy and convenience. Additionally, governments and non-profit organizations across the world are investing in family planning initiatives, further propelling the demand for hormonal contraceptives. Innovations in personalized medicine and an increased focus on minimizing side effects are likely to shape the future of this market, ensuring a more diversified product portfolio to meet consumer needs.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Ashutosh, Senior Research Analyst, 6Wresearch, The Americas have already achieved significant breakthroughs in the respective field. Ace K.Parellels Research & Consulting will launch a "Hormonal Contraceptives Market" product that will be available to farmers and purchases of their merchandise. The company is expanding the development of new products, which will be possible by the launching of five new products inclusively, within the first year period. The applicator of a hormonal contraceptive (device partner) projects to obtain a minimum share of 20% in the market in the near future due to the increasing awareness regarding contraception, the high prevalence of sex-related health problems, and the rise in the global population of pet animals.
Interrupted hormonal birth control is spoken for by the use of mini-pills (progestin-only), progesterone-releasing intrauterine devices (IUDs), and diaphragms with feminine barrier contraceptives, manufacturers are now following the demand for contraceptives. Underweight women may be strongly advised to stop taking these birth control pills. Around 135 million pill packs or other sources with as many as 30 million active women are accounting for its sales. Severe weight gain, rare allergies, VO2, and asthma are some of the drug's health and illegal side-effects of using the inhaler.
According to the needs, applications for mini-pills are also facetious. The various complexities of significant companies will not fail to be recognized; these may be placed as complementarities. The outflow of money in the pockets of the individual is reduced if free services are given. Hoot Foods, Inc., for example, has blueberries, apricots, golden raspberries, and red raspberries in their new sweetened purees. The development of new hybrids of plants by the bureau to help the farmers who can now plant the hybrids Agave nigra "Black Seed" and Agave McDougalli will encourage the negotiation with the buyers of these plants to obtain a reasonable amount of profit.
Between 25 and 34 years old, the highest demand for contraceptive pill is by women, who are the most fertile demographic group. Besides promotion of career-minded lifestyle, late childbirth, and thriving reproductive health consciousness are the factors behind the popularity of contraceptive methods among that generation. The availability of diverse contraceptive options meeting their needs continues to be a force that propels the market.
Hospitals will be the main end-users of hormonal contraceptives and will be the main areas where the contraceptives are distributed. It is common for women to go to healthcare professionals in hospitals for advice on which is the best contraceptive method to take, thus, the segment is likely to dominate the market. Also, Publicly Financed healthcare programs in hospitals improve access to contraceptive options thus touching on the growth of the market.
The report offers a comprehensive analysis of the following market segments
|
1 Executive Summary |
|
2 Introduction |
|
2.1 Key Highlights of the Report |
|
2.2 Report Description |
|
2.3 Market Scope & Segmentation |
|
2.4 Research Methodology |
|
2.5 Assumptions |
|
3 Global Hormonal Contraceptives Market Overview |
|
3.1 Global Regional Macro Economic Indicators |
|
3.2 Global Hormonal Contraceptives Market Revenues & Volume, 2021 & 2031F |
|
3.3 Global Hormonal Contraceptives Market - Industry Life Cycle |
|
3.4 Global Hormonal Contraceptives Market - Porter's Five Forces |
|
3.5 Global Hormonal Contraceptives Market Revenues & Volume Share, By Regions, 2021 & 2031F |
|
3.6 Global Hormonal Contraceptives Market Revenues & Volume Share, By Product, 2021 & 2031F |
|
3.7 Global Hormonal Contraceptives Market Revenues & Volume Share, By Hormone, 2021 & 2031F |
|
3.8 Global Hormonal Contraceptives Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
|
3.9 Global Hormonal Contraceptives Market Revenues & Volume Share, By End-users, 2021 & 2031F |
|
4 Global Hormonal Contraceptives Market Dynamics |
|
4.1 Impact Analysis |
|
4.2 Market Drivers |
|
4.3 Market Restraints |
|
5 Global Hormonal Contraceptives Market Trends |
|
6 Global Hormonal Contraceptives Market, 2021-2031 |
|
6.1 Global Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
6.2 Global Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
6.3 Global Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
6.4 Global Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
7 North America Hormonal Contraceptives Market, 2021-2031 |
|
7.1 North America Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
7.2 North America Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
7.3 North America Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
7.4 North America Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
8 Latin America Hormonal Contraceptives Market, 2021-2031 |
|
8.1 Latin America Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
8.2 Latin America Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
8.3 Latin America Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
8.4 Latin America Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
9 Europe Hormonal Contraceptives Market, 2021-2031 |
|
9.1 Europe Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
9.2 Europe Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
9.3 Europe Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
9.4 Europe Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
10 Asia Pacific Hormonal Contraceptives Market, 2021-2031 |
|
10.1 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
10.2 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
10.3 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
10.4 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
11 Middle East Hormonal Contraceptives Market, 2021-2031 |
|
11.1 Middle East Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
11.2 Middle East Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
11.3 Middle East Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
11.4 Middle East Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
12 Africa Hormonal Contraceptives Market, 2021-2031 |
|
12.1 Africa Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
|
12.2 Africa Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
|
12.3 Africa Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
|
12.4 Africa Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
|
13 Global Hormonal Contraceptives Market Key Performance Indicators |
|
14 Global Hormonal Contraceptives Market - Opportunity Assessment |
|
14.1 Global Hormonal Contraceptives Market Opportunity Assessment, By Regions, 2021 & 2031F |
|
14.2 Global Hormonal Contraceptives Market Opportunity Assessment, By Product, 2021 & 2031F |
|
14.3 Global Hormonal Contraceptives Market Opportunity Assessment, By Hormone, 2021 & 2031F |
|
14.4 Global Hormonal Contraceptives Market Opportunity Assessment, By Age Group, 2021 & 2031F |
|
14.5 Global Hormonal Contraceptives Market Opportunity Assessment, By End-users, 2021 & 2031F |
|
15 Global Hormonal Contraceptives Market - Competitive Landscape |
|
15.1 Global Hormonal Contraceptives Market Revenue Share, By Companies, 2021 |
|
15.2 Global Hormonal Contraceptives Market Competitive Benchmarking, By Operating and Technical Parameters |
|
16 Company Profiles |
|
17 Recommendations |
|
18 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here